New aspects in the treatment of immunomediated diseases.
The following constitutes a summary of lectures delivered during the session "New aspects in the treatment of immunomediated diseases" which was held during the 25th Annual Scientific Meeting of the European Society for Clinical Investigation in Pisa, Italy on 6th April 1991. The aim of this session was to present and discuss some of the novel therapeutic modalities currently being employed either in experimental models or in phase I clinical studies.
Steinmetz Research Unit of Autoimmune Diseases, Department of Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.
Y
Y
Shoenfeld
S
S
Ferrone
S
S
Bombardieri
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000628:therapy; D001327:Autoimmune Diseases / Q000628:therapy*; D001781:Blood Component Removal; D015704:CD4 Antigens / Q000276:immunology; D015267:Churg-Strauss Syndrome / Q000188:drug therapy; D003449:Cryoglobulinemia / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004306:Dose-Response Relationship, Immunologic; D004341:Drug Evaluation; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007105:Immune Complex Diseases / Q000188:drug therapy; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007167:Immunotherapy; D016898:Interferon-alpha / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D051381:Rats; D011919:Rats, Inbred Strains; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000276:Adjuvants, Immunologic; D000906:Antibodies; D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D000949:Histocompatibility Antigens Class II; D007130:Immunoglobulin Idiotypes; D016756:Immunoglobulins, Intravenous; D016898:Interferon-alpha; D016572:Cyclosporine